跳至主要内容
临床试验/NCT02389335
NCT02389335已完成不适用

Roles of Interferon Gamma, Interleukin-2 and Tumor Necrotizan Factor Alpha in the Pathogenesis of Type 1 Diabetes

Istanbul Medeniyet University1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2013年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
128
试验地点
1
主要终点
Roles of interferon gamma, interleukin-2, tumor necrotizan factor alpha in the pathogenesis of type 1 diabetes

研究概览

简要总结

The mechanism of β cell destruction in Type 1 diabetes is not exactly known, Our hyphotesis is that interferon gamma, interleukin-2 and tumor necrotizan factor alpha have impotant roles in β cell destruction.

详细描述

T helper (h)1 cells are known to have important roles in the destruction or/and dedifferentiation of β-cells in type 1 diabetes (T1D). Significant increase in IFN-γ-producing Th1 cells in the pancreas and in the serum levels were determined in type 1 diabetic patients at diabetes oneset. This data indicated that this proinflammatory mediator serve as a biomarker of advanced autoimmunity. We aimed to investigate the relationship between Th1 cytokines (IFN-γ, IL-2 and TNF-α) and T1D and the effect of those cytokines on β-cell function.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients giving consent to participate the study
  • Patients with type 1 diabetes according to WHO definiton

排除标准

  • Acute and chronic inflammatory diseases,
  • significant concomitant diseases which may interfere with glucose metabolism
  • hemoglobinopathies,
  • recently received antibiotics,
  • drugs influencing β-cell function and
  • insulin sensitivity or anti-inflammatory drugs
  • recent history of trauma

结局指标

主要结局

Roles of interferon gamma, interleukin-2, tumor necrotizan factor alpha in the pathogenesis of type 1 diabetes

时间窗: 3 day

次要结局

未报告次要终点

研究者

发起方
Istanbul Medeniyet University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Gonca Incemehmet Tamer

Assoc prof

Istanbul Medeniyet University

研究点 (1)

Loading locations...

相似试验

Roles of T Helper 1 Cytokines in Type 1 Diabetes | 临床试验